Trade Mark Journal No.2026/037 11 September 2026
WO0000001934327 (5,42)
Office of origin: United States of America
Date of International Registration:16 June 2026
Date of designation in the UK:
16 June 2026
The mark consists of the stacked literal elements "IOLYX THERAPEUTICS" to the right of the design of an abstract six pointed star with the opposite points forming almond shapes and in the center of which is a circle with a highlight crescent at the upper right of the circle, resembling an eye.
International priority date claimed: 26 December 2025
(United States of America)
(99566643)
- Class 5
- Pharmaceutical preparations for the treatment and prevention of ophthalmological, immunological, and inflammatory diseases and disorders.
- Class 42
- Pharmaceutical research and development; medical and scientific research in the field of pharmaceutical development; providing scientific information in the field of pharmaceutical development, namely, providing information about scientific research related to development of pharmaceuticals; medical and scientific research information in the field of pharmaceutical development, namely, providing information about medical and scientific research related to development of pharmaceuticals.
Iolyx Therapeutics, Inc.
Representative: Susan Piascik Christoff Cooley LLP, 1299 Pennsylvania Avenue, NW, Suite 700, Washington DC 20004, UNITED STATES OF AMERICA